ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,225.33
-0.27%
Dow Jones
39,127.80
0.04%
Gold vs US Dollar
2,297.73
-0.99%
Brent Oil
84.425
0.29%
Bitcoin
60,861.01
-1.54%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bicycle Therapeutics PLC (BCYC)

  7. Bicycle Therapeutics PLC (BCYC) News

Bicycle Therapeutics (BCYC)

Bicycle Therapeutics PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCYC
DateTimeSourceHeadlineSymbolCompany
18/06/202421:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCYCBicycle Therapeutics PLC
18/06/202421:14Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:BCYCBicycle Therapeutics PLC
03/06/202412:00Business WireBicycle Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BCYCBicycle Therapeutics PLC
23/05/202422:05Business WireBicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual MeetingNASDAQ:BCYCBicycle Therapeutics PLC
23/05/202421:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCYCBicycle Therapeutics PLC
23/05/202412:00Business WireBicycle Therapeutics Announces $555 Million Private Placement Equity FinancingNASDAQ:BCYCBicycle Therapeutics PLC
16/05/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCYCBicycle Therapeutics PLC
02/05/202412:00Business WireBicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial ResultsNASDAQ:BCYCBicycle Therapeutics PLC
24/04/202415:05Business WireBicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual MeetingNASDAQ:BCYCBicycle Therapeutics PLC
02/04/202412:00Business WireBicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
05/03/202421:35Business WireBicycle Therapeutics to Present at the AACR Annual Meeting 2024NASDAQ:BCYCBicycle Therapeutics PLC
28/02/202412:00Business WireBicycle Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BCYCBicycle Therapeutics PLC
21/02/202421:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
21/02/202421:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
20/02/202413:38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BCYCBicycle Therapeutics PLC
20/02/202412:19Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BCYCBicycle Therapeutics PLC
20/02/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCYCBicycle Therapeutics PLC
20/02/202412:05Business WireBicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BCYCBicycle Therapeutics PLC
14/02/202421:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCYCBicycle Therapeutics PLC
14/02/202413:37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCYCBicycle Therapeutics PLC
07/02/202412:00Business WireBicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
04/01/202423:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
04/01/202423:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
04/01/202423:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
04/01/202423:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
04/01/202423:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
04/01/202423:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
04/01/202423:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
04/01/202423:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
04/01/202423:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
 Showing the most relevant articles for your search:NASDAQ:BCYC

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
QBT
Quantum Blockchain Techn...
LSE
POS
Plexus
LSE
AAZ
Anglo Asian Mining
LSE
PHNX
Phoenix
LSE
EEE
Empire Metals
LSE
GKP
Gulf Keystone Petroleum
LSE
VAST
Vast Resources
LSE
ENET
Ethernity Networks
LSE
THG
Thg
LSE
TERN
Tern
LSE
GMET
Golden Metal Resources
LSE
ALTN
Altyngold
LSE
AAU
Ariana Resources
LSE
GDR
Genedrive
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved